AMPK, an energy consumption supervisor, regulates hedgehog and may be a cancer therapeutic target
A cell can be thought of as a factory with many machines controlling different processes. Cell growth is the process by which a cell divides and multiplies. It is a highly energy-consuming process. Therefore, supervisors are needed to oversee the factory operations such that the cell does not overuse its energy.
When a cell is stressed or lacking energy, cell growth must slow down to save energy. In this scenario, a supervisor called AMP kinase (AMPK) takes charge. A kinase is a protein that transfers phosphate groups to other proteins. Specifically, AMPK can control cell growth by regulating a chain reaction known as the hedgehog pathway. The hedgehog pathway can be seen as a machine that controls cell growth by producing proteins that promote cell growth. One such major protein it produces is Gli1. Gli1 is regarded as an ultimate activator of the hedgehog pathway; it is a transcription factor, which is a protein that can control the production of even more proteins. Specifically, Gli1 directs the production of proteins that regulate cell growth, and in various cancers, the production of Gli1 is amplified.
AMPK controls the hedgehog pathway by adding modifications to proteins in the pathway. These modifications can either switch on or off the activity of these proteins. For example, AMPK adds a phosphate group to Gli1. This modification of Gli1 protein slows down the transcriptional activity of Gli1 so the pathway does not produce as many necessary proteins for cell growth. This in turn decreases cell energy expenses. In this way, AMPK can control energy costs in response to the environmental cues in the cell.
Imagine if a machine malfunctions, it might produce too much of a product. Too much of the production of Gli1 in the hedgehog pathway promotes abnormal, uncontrolled cell growth, and indeed, this is what happens in diseases such as cancer. Since AMPK activity shuts off the cell growth-promoting function of Gli1, it makes sense that if we induce AMPK activity, we can downplay the action of Gli1. This makes AMPK a potential drug target in cancer therapy.
Sherri Y. Huang1 and Jer-Yen Yang2,3
1Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis,
2Department of Basic Medical Sciences,
3Center for Cancer Research, Purdue University College of Veterinary Medicine, West Lafayette,
AMP-Activated Protein Kinase Directly Phosphorylates and Destabilizes Hedgehog Pathway Transcription Factor GLI1 in Medulloblastoma.
Li YH, Luo J, Mosley YY, Hedrick VE, Paul LN, Chang J, Zhang G, Wang YK, Banko MR, Brunet A, Kuang S, Wu JL, Chang CJ, Scott MP, Yang JY.
Cell Rep. 2015 Jul 28